HIV-TAT mediated protein transduction of Cu/Zn-superoxide dismutase-1 (SOD1) protects skin cells from ionizing radiation

Radiation Oncology

Volumn 8, Issue 1, 2013, Pages

  Gu, Qing ^a   Feng, Tienan ^b   Cao, Han ^c   Tang, Yiting ^a   Ge, Xin ^a   Luo, Judong ^d   Xue, Jiao ^a   Wu, Jinyong ^e   Yang, Hongying ^a   Zhang, Shuyu ^a   Cao, Jianping ^a  

^a MEDICAL COLLEGE OF SOOCHOW UNIVERSITY   (China)

^b TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

^c BD Rapid Diagnostics (Suzhou) Co Ltd   (China)

^d SOOCHOW UNIVERSITY   (China)

^e INSTITUTE OF PLASMA PHYSICS   (China)

Author keywords

Cu Zn superoxide dismutase (SOD1); HIV TAT domain; Protein transduction domain (PTD); Radiation induced skin injury

Indexed keywords

ANTIOXIDANT; COPPER ZINC SUPEROXIDE DISMUTASE; DOUBLE STRANDED DNA; HISTONE H2AX; HYBRID PROTEIN; MALONALDEHYDE; REACTIVE OXYGEN METABOLITE; RECOMBINANT TRANSACTIVATOR PROTEIN TRANSDUCTION DOMAIN MEDIATED PROTEIN TRANSDUCTION OF COPPER ZINC SUPEROXIDE DISMUTASE; TRANSACTIVATOR PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; BIOLOGICAL ACTIVITY; CELL ASSAY; CELL PROTECTION; CELL VIABILITY; CONTROLLED STUDY; DOUBLE STRANDED DNA BREAK; ELECTRON THERAPY; EXPRESSION VECTOR; GENE EXPRESSION SYSTEM; GENE INDUCTION; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IONIZING RADIATION; KERATINOCYTE; MALE; MITOCHONDRION; NONHUMAN; PROKARYOTE; PROTEIN EXPRESSION; PROTEIN TRANSPORT; RADIATION EXPOSURE; RADIATION INJURY; RADIATION PROTECTION; RAT; SKIN CELL; SKIN INJURY; SKIN PROTECTION; TISSUE LEVEL; X IRRADIATION;

ANIMALS; ANTIOXIDANTS; APOPTOSIS; CELL LINE; CELL MEMBRANE; CELL SURVIVAL; DNA BREAKS, DOUBLE-STRANDED; FREE RADICAL SCAVENGERS; HISTONES; HUMANS; KERATINOCYTES; MALE; MALONDIALDEHYDE; PHOSPHOPROTEINS; PROTEIN TRANSPORT; RADIATION, IONIZING; RATS; RATS, SPRAGUE-DAWLEY; REACTIVE OXYGEN SPECIES; RECOMBINANT PROTEINS; SKIN; SUPEROXIDE DISMUTASE; SUPEROXIDES; TAT GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; X-RAYS;

EID: 84887622853     PISSN: None     EISSN: 1748717X     Source Type: Journal    
DOI: 10.1186/1748-717X-8-253     Document Type: Article

References (48)

1. Baskar R, Lee KA, Yeo R, Yeoh KW. Cancer and radiation therapy: current advances and future directions. Int J Med Sci 2012, 9:193-199. 10.7150/ijms.3635, 3298009, 22408567.
2. Ryan JL. Ionizing radiation: the good, the bad, and the ugly. J Invest Dermatol 2012, 132:985-993. 10.1038/jid.2011.411, 3779131, 22217743.
3. Riley PA. Free radicals in biology: oxidative stress and the effects of ionizing radiation. Int J Radiat Biol 1994, 65:27-33. 10.1080/09553009414550041, 7905906.
4. Liochev SI, Fridovich I. Mechanism of the peroxidase activity of Cu, Zn superoxide dismutase. Free Radic Biol Med 2010, 48:1565-1569. 10.1016/j.freeradbiomed.2010.02.036, 20211248.
5. Halliwell B, Gutteridge JM. Role of free radicals and catalytic metal ions in human disease: an overview. Methods Enzymol 1990, 186:1-85.
6. Jin LH, Bahn JH, Eum WS, Kwon HY, Jang SH, Han KH, Kang TC, Won MH, Kang JH, Cho SW, et al. Transduction of human catalase mediated by an HIV-1 TAT protein basic domain and arginine-rich peptides into mammalian cells. Free Radic Biol Med 2001, 31:1509-1519. 10.1016/S0891-5849(01)00734-1, 11728823.
7. Eum WS, Choung IS, Li MZ, Kang JH, Kim DW, Park J, Kwon HY, Choi SY. HIV-1 Tat-mediated protein transduction of Cu, Zn-superoxide dismutase into pancreatic beta cells in vitro and in vivo. Free Radic Biol Med 2004, 37:339-349. 10.1016/j.freeradbiomed.2004.04.036, 15223067.
8. Kim DW, Eum WS, Jang SH, Kim SY, Choi HS, Choi SH, An JJ, Lee SH, Lee KS, Han K, et al. Transduced Tat-SOD fusion protein protects against ischemic brain injury. Mol Cells 2005, 19:88-96.
9. Kimura H, Minakami H, Otsuki K, Shoji A. Cu-Zn superoxide dismutase inhibits lactate dehydrogenase release and protects against cell death in murine fibroblasts pretreated with ultraviolet radiation. Cell Biol Int 2000, 24:459-465. 10.1006/cbir.2000.0513, 10875893.
10. Wu Y, Ren C, Gao Y, Hou B, Chen T, Zhang C. A novel method for promoting heterologous protein expression in Escherichia coli by fusion with the HIV-1 TAT core domain. Amino Acids 2010, 39:811-820. 10.1007/s00726-010-0534-2, 20213440.
11. Frankel AD, Pabo CO. Cellular uptake of the tat protein from human immunodeficiency virus. Cell 1988, 55:1189-1193. 10.1016/0092-8674(88)90263-2, 2849510.
12. Green M, Loewenstein PM. Autonomous functional domains of chemically synthesized human immunodeficiency virus tat trans-activator protein. Cell 1988, 55:1179-1188. 10.1016/0092-8674(88)90262-0, 2849509.
13. Fawell S, Seery J, Daikh Y, Moore C, Chen LL, Pepinsky B, Barsoum J. Tat-mediated delivery of heterologous proteins into cells. Proc Natl Acad Sci USA 1994, 91:664-668. 10.1073/pnas.91.2.664, 43009, 8290579.
14. Schwarze SR, Ho A, Vocero-Akbani A, Dowdy SF. In vivo protein transduction: delivery of a biologically active protein into the mouse. Science 1999, 285:1569-1572. 10.1126/science.285.5433.1569, 10477521.
15. Watson K, Edwards RJ. HIV-1-trans-activating (Tat) protein: both a target and a tool in therapeutic approaches. Biochem Pharmacol 1999, 58:1521-1528. 10.1016/S0006-2952(99)00209-9, 10535742.
16. Wadia JS, Dowdy SF. Protein transduction technology. Curr Opin Biotechnol 2002, 13:52-56. 10.1016/S0958-1669(02)00284-7, 11849958.
17. Zhang X, Wang F. Intracellular transduction and potential of Tat PTD and its analogs: from basic drug delivery mechanism to application. Expert Opin Drug Deliv 2012, 9:457-472. 10.1517/17425247.2012.663351, 22432469.
18. Spitere K, Toulouse A, O'Sullivan DB, Sullivan AM. TAT-PAX6 protein transduction in neural progenitor cells: a novel approach for generation of dopaminergic neurones in vitro. Brain Res 2008, 1208:25-34.
19. Ye N, Liu S, Lin Y, Rao P. Protective effects of intraperitoneal injection of TAT-SOD against focal cerebral ischemia/reperfusion injury in rats. Life Sci 2011, 89:868-874. 10.1016/j.lfs.2011.09.015, 21983418.
20. Hernandez Losa J, Parada Cobo C, Guinea Viniegra J, Sanchez-Arevalo Lobo VJ, Ramon y Cajal S, Sanchez-Prieto R. Role of the p38 MAPK pathway in cisplatin-based therapy. Oncogene 2003, 22:3998-4006. 10.1038/sj.onc.1206608, 12821934.
21. Boukamp P, Popp S, Bleuel K, Tomakidi E, Burkle A, Fusenig NE. Tumorigenic conversion of immortal human skin keratinocytes (HaCaT) by elevated temperature. Oncogene 1999, 18:5638-5645. 10.1038/sj.onc.1202934, 10523843.
22. Zhang S, Song C, Zhou J, Xie L, Meng X, Liu P, Cao J, Zhang X, Ding WQ, Wu J. Amelioration of radiation-induced skin injury by adenovirus-mediated heme oxygenase-1 (HO-1) overexpression in rats. Radiat Oncol 2012, 7:4. 10.1186/1748-717X-7-4, 3282628, 22247972.
23. Kim EH, Sohn S, Kwon HJ, Kim SU, Kim MJ, Lee SJ, Choi KS. Sodium selenite induces superoxide-mediated mitochondrial damage and subsequent autophagic cell death in malignant glioma cells. Cancer Res 2007, 67:6314-6324. 10.1158/0008-5472.CAN-06-4217, 17616690.
24. Lemasters JJ, Nieminen AL, Qian T, Trost LC, Elmore SP, Nishimura Y, Crowe RA, Cascio WE, Bradham CA, Brenner DA, et al. The mitochondrial permeability transition in cell death: a common mechanism in necrosis, apoptosis and autophagy. Biochim Biophys Acta 1998, 1366:177-196. 10.1016/S0005-2728(98)00112-1, 9714796.
25. Yang J, Wu LJ, Tashino S, Onodera S, Ikejima T. Reactive oxygen species and nitric oxide regulate mitochondria-dependent apoptosis and autophagy in evodiamine-treated human cervix carcinoma HeLa cells. Free Radic Res 2008, 42:492-504. 10.1080/10715760802112791, 18484413.
26. Freeman BA, Young SL, Crapo JD. Liposome-mediated augmentation of superoxide dismutase in endothelial cells prevents oxygen injury. J Biol Chem 1983, 258:12534-12542.
27. Lefaix JL, Delanian S, Leplat JJ, Tricaud Y, Martin M, Nimrod A, Baillet F, Daburon F. Successful treatment of radiation-induced fibrosis using Cu/Zn-SOD and Mn-SOD: an experimental study. Int J Radiat Oncol Biol Phys 1996, 35:305-312. 10.1016/0360-3016(96)00061-2, 8635938.
28. Epperly M, Bray J, Kraeger S, Zwacka R, Engelhardt J, Travis E, Greenberger J. Prevention of late effects of irradiation lung damage by manganese superoxide dismutase gene therapy. Gene Ther 1998, 5:196-208. 10.1038/sj.gt.3300580, 9578839.
29. Delanian S, Baillet F, Huart J, Lefaix JL, Maulard C, Housset M. Successful treatment of radiation-induced fibrosis using liposomal Cu/Zn superoxide dismutase: clinical trial. Radiother Oncol 1994, 32:12-20. 10.1016/0167-8140(94)90444-8, 7938674.
30. Tsubokawa T, Jadhav V, Solaroglu I, Shiokawa Y, Konishi Y, Zhang JH. Lecithinized superoxide dismutase improves outcomes and attenuates focal cerebral ischemic injury via antiapoptotic mechanisms in rats. Stroke 2007, 38:1057-1062. 10.1161/01.STR.0000257978.70312.1d, 17272760.
31. Reddy MK, Labhasetwar V. Nanoparticle-mediated delivery of superoxide dismutase to the brain: an effective strategy to reduce ischemia-reperfusion injury. FASEB J 2009, 23:1384-1395. 10.1096/fj.08-116947, 19124559.
32. Perrone S, Usai M, Lazzari P, Tucker SJ, Wallace HM, Zanda M. Efficient cell transfection with melamine-based gemini surfactants. Bioconjug Chem 2013, 24:176-187. 10.1021/bc3004292, 23297813.
33. Biswas J, Mishra SK, Kondaiah P, Bhattacharya S. Syntheses, transfection efficacy and cell toxicity properties of novel cholesterol-based gemini lipids having hydroxyethyl head group. Org Biomol Chem 2011, 9:4600-4613. 10.1039/c0ob00940g, 21537498.
34. Hou CL, Huang Q, Wei Y, Zhang W, Mi JH, Ying DJ, Zhou ZH. Protein transduction domain-hA20 fusion protein protects endothelial cells against high glucose-induced injury. Genet Mol Res 2012, 11:1899-1908. 10.4238/2012.July.19.9, 22869545.
35. Suhorutsenko J, Oskolkov N, Arukuusk P, Kurrikoff K, Eriste E, Copolovici DM, Langel U. Cell-penetrating peptides, PepFects, show no evidence of toxicity and immunogenicity in vitro and in vivo. Bioconjug Chem 2011, 22:2255-2262. 10.1021/bc200293d, 21978260.
36. Stewart KM, Horton KL, Kelley SO. Cell-penetrating peptides as delivery vehicles for biology and medicine. Org Biomol Chem 2008, 6:2242-2255. 10.1039/b719950c, 18563254.
37. Gutowski M, Kowalczyk S. A study of free radical chemistry: their role and pathophysiological significance. Acta Biochim Pol 2013, 60:1-16.
38. Gollapalle E, Wang R, Adetolu R, Tsao D, Francisco D, Sigounas G, Georgakilas AG. Detection of oxidative clustered DNA lesions in X-irradiated mouse skin tissues and human MCF-7 breast cancer cells. Radiat Res 2007, 167:207-216. 10.1667/RR0659.1, 17390728.
39. Rugo RE, Schiestl RH. Increases in oxidative stress in the progeny of X-irradiated cells. Radiat Res 2004, 162:416-425. 10.1667/RR3238, 15447041.
40. Yoshida T, Goto S, Kawakatsu M, Urata Y, Li TS. Mitochondrial dysfunction, a probable cause of persistent oxidative stress after exposure to ionizing radiation. Free Radic Res 2012, 46:147-153. 10.3109/10715762.2011.645207, 22126415.
41. Keeble JA, Gilmore AP. Apoptosis commitment-translating survival signals into decisions on mitochondria. Cell Res 2007, 17:976-984. 10.1038/cr.2007.101, 18071367.
42. Kamat JP, Devasagayam TP. Oxidative damage to mitochondria in normal and cancer tissues, and its modulation. Toxicology 2000, 155:73-82. 10.1016/S0300-483X(00)00279-1, 11154799.
43. Pal PB, Sinha K, Sil PC. Mangiferin, a natural xanthone, protects murine liver in pb(II) induced hepatic damage and cell death via MAP kinase, NF-kappaB and Mitochondria Dependent Pathways. PLoS One 2013, 8:e56894. 10.1371/journal.pone.0056894, 3581562, 23451106.
44. Dong GZ, Jang EJ, Kang SH, Cho IJ, Park SD, Kim SC, Kim YW. Red ginseng abrogates oxidative stress via mitochondria protection mediated by LKB1-AMPK pathway. BMC Complement Altern Med 2013, 13:64. 10.1186/1472-6882-13-64, 3635924, 23506615.
45. Huang Z. Bcl-2 family proteins as targets for anticancer drug design. Oncogene 2000, 19:6627-6631. 10.1038/sj.onc.1204087, 11426648.
46. Byrne GI, Ojcius DM. Chlamydia and apoptosis: life and death decisions of an intracellular pathogen. Nat Rev Microbiol 2004, 2:802-808. 10.1038/nrmicro1007, 15378044.
47. Ngwa W, Korideck H, Kassis AI, Kumar R, Sridhar S, Makrigiorgos GM, Cormack RA. In vitro radiosensitization by gold nanoparticles during continuous low-dose-rate gamma irradiation with I-125 brachytherapy seeds. Nanomedicine 2013, 9:25-27. 10.1016/j.nano.2012.09.001, 23041410.
48. Niu Y, Wang H, Wiktor-Brown D, Rugo R, Shen H, Huq MS, Engelward B, Epperly M, Greenberger JS. Irradiated esophageal cells are protected from radiation-induced recombination by MnSOD gene therapy. Radiat Res 2010, 173:453-461. 10.1667/RR1763.1, 2872095, 20334517.